MedPath

The efficacy of topical tranexamic acid in reducing blood loss after direct anterior hip replacement in osteoporotic femoral neck fracture patients

Phase 2
Completed
Conditions
total hemoglobin loss total pack red cell transfusion during perioperative peroid incidence of deep vein thrombosis
topical tranexamic acid
hip fracture
blood loss
complication
hip replacement
Registration Number
TCTR20200428006
Lead Sponsor
none
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

osteoporotic hip fracture
muscle spairing surgical hip approach
underwent hip replacement

Exclusion Criteria

pre-exiting deep vein thrombosis
multiple fracture
bleeding disorder
non-stoping anti-platelet prior surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
total hemoglobin loss at post op day 0, day 1, day 2 and day 3 g/dl
Secondary Outcome Measures
NameTimeMethod
total blood transfusion rate perioperative peroid unit,symptomatic deep vein thrombosis perioperative peroid patient number
© Copyright 2025. All Rights Reserved by MedPath